V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20217607 | 20082956 | null | null | null | null | 2018-10-22 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100351945 |
| 20217609 | 20082957 | null | null | null | 2017-01-06 | 2017-01-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 100128848 |
| 20217614 | 20082960 | 1.68 | 58.7 | Palliative (P) | null | 2017-04-20 | null | null | N | CISPLATIN + ETOPOSIDE | 101795127 |
| 20217617 | 20082961 | 1.71 | 86 | Palliative (P) | null | 2016-07-23 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100543322 |
| 20217626 | 20082963 | null | null | null | null | 2019-08-13 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100349850 |
| 20217630 | 20082964 | 1.88 | 58.2 | Palliative (P) | 2016-05-05 | 2016-05-20 | CAPECITABINE + CISPLATIN + Trastuzumab | N | N | HCX | 101483077 |
| 20217635 | 20082965 | 1.6 | 98.6 | Palliative (P) | null | 2019-05-05 | null | null | N | LENVATINIB | 100564512 |
| 20217636 | 20082966 | 1.56 | 72 | Palliative (P) | null | 2016-09-29 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100000610 |
| 20217646 | 20082968 | 1.8 | 60.1 | Palliative (P) | 2019-07-17 | 2019-07-31 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100392552 |
| 20217650 | 20082969 | null | 48.9 | Curative (C) | 2019-03-20 | 2019-03-22 | null | null | Y | CAPECITABINE + IRINOTECAN | 101748297 |
| 20217652 | 20082970 | 1.81 | 60 | Neo-adjuvant (N) | 2018-11-24 | 2018-12-15 | ECF | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100843973 |
| 20217654 | 20082972 | 1.64 | 95.4 | Neo-adjuvant (N) | 2018-04-15 | 2018-04-25 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100074409 |
| 20217655 | 20082973 | 1.65 | 70.6 | Palliative (P) | null | 2019-05-25 | null | null | N | HCX | 101732104 |
| 20217656 | 20082974 | 1.7 | 55 | null | 2018-04-11 | 2018-04-18 | null | null | 2 | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100091496 |
| 20217664 | 20082975 | 1.72 | 95 | Neo-adjuvant (N) | 2017-09-02 | 2017-09-02 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 100023910 |
| 20217669 | 20082978 | 1.65 | 0 | Palliative (P) | 2016-11-29 | 2016-11-29 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101186124 |
| 20217670 | 20082979 | 1.64 | 66.9 | Palliative (P) | null | 2017-01-20 | null | null | null | CISPLATIN + ETOPOSIDE | 101866584 |
| 20217672 | 20082980 | 1.75 | 59.8 | Palliative (P) | 2019-08-09 | 2019-08-10 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | HCX | 101750102 |
| 20217673 | 20082981 | null | 87 | Neo-adjuvant (N) | 2018-02-23 | 2018-02-23 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101869569 |
| 20217674 | 20082982 | 1.16 | null | Palliative (P) | null | 2016-02-23 | null | null | N | CAPECITABINE + IRINOTECAN | 100202756 |
| 20217679 | 20082985 | 1.9 | 54 | Palliative (P) | 2017-09-02 | 2017-09-03 | Capecitabine (14 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101404586 |
| 20217683 | 20082986 | 1.76 | 63.4 | Palliative (P) | 2020-01-27 | 2020-03-11 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + MITOMYCIN + RT | 101607137 |
| 20217690 | 20082990 | 1.62 | 54.7 | Neo-adjuvant (N) | null | 2019-03-01 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100620826 |
| 20217692 | 20082991 | 1.6 | 84 | Palliative (P) | 2019-03-03 | 2019-03-16 | ECarboX | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100786473 |
| 20217696 | 20082992 | null | null | null | 2016-09-12 | 2016-09-16 | null | null | null | CAPECITABINE + IRINOTECAN | 100550382 |
| 20217697 | 20082993 | 1.61 | 80.9 | Palliative (P) | null | 2018-07-29 | null | null | null | CISPLATIN + ETOPOSIDE | 101455143 |
| 20217702 | 20082995 | null | null | null | 2017-03-10 | 2017-03-22 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | CETUXIMAB + IRINOTECAN + MDG | 100297476 |
| 20217703 | 20082996 | 1.53 | 71 | Palliative (P) | 2016-10-27 | 2016-11-02 | Cape+Cisplatin+Trastuzumab Load | 02 | N | HCX | 101579856 |
| 20217705 | 20082997 | 1.82 | 66.2 | Neo-adjuvant (N) | 2017-06-19 | 2017-06-22 | ECarboX | 02 | null | HCX | 100788944 |
| 20217711 | 20082998 | null | null | null | 2018-12-24 | 2018-12-27 | Cisplatin + Etoposide po&iv 3 day | N | null | CISPLATIN + ETOPOSIDE | 100298065 |
| 20217718 | 20082999 | null | null | null | null | 2019-05-27 | null | null | null | CISPLATIN + ETOPOSIDE | 101468388 |
| 20217719 | 20083000 | 1.58 | 97 | Palliative (P) | null | 2019-07-30 | null | null | N | LENVATINIB | 100624655 |
| 20217724 | 20083002 | 0 | 65.9 | Palliative (P) | 2018-11-20 | 2018-11-21 | ECarboX | null | N | CETUXIMAB + IRINOTECAN + MDG | 100290850 |
| 20217725 | 20083003 | null | null | null | null | 2018-09-12 | null | null | null | LENVATINIB | 100606192 |
| 20217737 | 20083004 | null | null | null | 2022-02-07 | 2022-02-14 | LENVATINIB | 02 | null | LENVATINIB | 101823263 |
| 20217738 | 20083005 | null | null | null | 2016-11-25 | 2016-12-16 | null | null | null | CAPECITABINE + IRINOTECAN | 101110137 |
| 20217741 | 20083006 | 1.66 | 76.3 | Palliative (P) | null | 2018-05-26 | null | null | N | CAPECITABINE + IRINOTECAN | 100983153 |
| 20217742 | 20083007 | null | null | null | null | 2016-11-18 | null | null | null | LENVATINIB | 100169774 |
| 20217748 | 20083008 | 1.6 | 79 | Palliative (P) | 2018-10-26 | 2018-10-26 | LENVATINIB | 02 | N | LENVATINIB | 100866559 |
| 20217752 | 20083009 | null | null | null | null | 2018-02-10 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101566733 |
| 20217753 | 20083010 | null | null | null | 2017-04-14 | 2017-08-12 | LENVATINIB | 02 | null | LENVATINIB | 100190153 |
| 20217757 | 20083012 | 1.61 | 55 | Palliative (P) | 2017-03-18 | 2017-03-31 | Cape+Cisplatin+Trastuzumab Load | N | N | HCX | 100607817 |
| 20217759 | 20083013 | 1.8 | 51 | Palliative (P) | null | 2016-06-20 | null | null | N | LENVATINIB | 100948729 |
| 20217775 | 20083017 | 1.82 | null | null | 2017-11-16 | 2017-12-06 | Cape+Cisplatin+Trastuzumab Load | N | null | HCX | 101211440 |
| 20217776 | 20083018 | 1.81 | 103.5 | Palliative (P) | 2019-11-07 | 2019-11-14 | null | null | N | CISPLATIN + ETOPOSIDE | 101286041 |
| 20217778 | 20083019 | null | null | null | null | 2017-01-13 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100099732 |
| 20217781 | 20083020 | null | null | null | 2019-03-19 | 2019-04-24 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + IRINOTECAN + MDG | 100499828 |
| 20217784 | 20083021 | 1.66 | 51 | null | null | 2020-01-17 | null | null | null | LENVATINIB | 100270878 |
| 20217789 | 20083022 | 1.56 | 60.7 | Neo-adjuvant (N) | 2019-12-30 | 2019-12-30 | ECF | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101179762 |
| 20217790 | 20083023 | null | null | null | null | 2016-11-16 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101694068 |